Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Recurrent Urinary Tract Infections
NCT06050148Phase 3Recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Aug 2023
- Primary completion
- Dec 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of fecal microbiome transplant in urinary tract infection (UTI), sponsored by Helsinki University Hospital. Started Aug 2023; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06050148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06050148.